Global Regulatory Partners Brazil and Mexico Registration Holder vs bioaccess®

Global Regulatory Partners (GRP) vs bioaccess®: what Global Regulatory Partners (GRP) publishes, and when a one-country or dossier partner is enough versus the bioaccess® registration holder across Latin America.

Global Regulatory Partners (GRP) shows up when manufacturers search for a Latin American registration holder or sanitary-registration partner. This article uses only what Global Regulatory Partners (GRP) publishes on its own site (globalregulatorypartners.com/registration-holder-for-medical-devices-imported-from-mexico · globalregulatorypartners.com/countries/brazils-anvisa), then compares it with the multi-country subscription from bioaccess®. It is a practitioner comparison, not a teardown.

What Global Regulatory Partners (GRP) publishes

Global Regulatory Partners (GRP) is a Massachusetts regulatory firm with affiliates in China, Japan, Brazil and Mexico. Its public pages say GRP-Brazil is licensed by ANVISA to act as Brazilian Registration Holder, and that GRP Mexico is COFEPRIS-licensed to act as Mexico Registration Holder and local representative. The Mexico page pitches an independent holder, so a manufacturer can add distributors without handing them the dossier, and also lists importation, warehousing and distribution.

Global Regulatory Partners (GRP) vs bioaccess®

Dimension Global Regulatory Partners (GRP) bioaccess®
Public product ANVISA BRH and COFEPRIS MRH through its own licensed affiliates; Mexico import, warehousing, distribution LATAM medical device registration: registration, in-country holder, certified translations, government fees up to a stated cap, tecnovigilancia (import shipments quoted separately)
Geography Brazil and Mexico 19 LATAM markets
Public pricing None published Published two-part pricing: a one-time registration fee by country and class, plus an annual holder fee from year 2 (rate card)
Holder vs distributor GRP Mexico files as primary holder and adds the manufacturer's distributors to the registration without giving them control of, or access to, confidential information; a holder transfer needs the original holder's notarized consent Holds through its own in-country entities, with defined transfer provisions; the registration is never leverage
Bridge from a clinical trial None published Trial-to-Market continuity: the same partner that ran your FIH study can carry registration (see market access)

Where each one fits

If Brazil and Mexico are the only Latin American markets on the plan, and you also want GRP for China or Japan, its own-affiliate model covers that job.

The LATAM medical device registration service from bioaccess® is a different product. bioaccess® registers already FDA-cleared or CE-marked devices and holds them through its own in-country entities across 19 Latin American markets, including COFEPRIS, ANVISA, INVIMA, ANMAT, ISP and DIGEMID. Pricing is published as two parts: a one-time registration fee by country and device class, plus an annual holder fee from year 2 (see the rate card). Initial government fees and certified translations are included up to a stated cap, and the first 12 months of holder service are included (importer-of-record shipments are priced separately on the hub). For multi-country pricing, contact us or see the rate card. The registration is held for the manufacturer’s benefit, with defined transfer provisions if you ever change partners or set up your own entity.

One country and one local partner is enough? Hire the firm that publishes that job. Several LATAM labels under one holder who is not your distributor? Start at bioaccess® market access, read the LATAM importer of record guide, try the LATAM Launch Calculator, or request a registration quote.

Competitor facts from the Global Regulatory Partners (GRP) public pages linked above, reviewed for bioaccess® competitive research (Aug 2026–Nov 2026). Claims are theirs. No invented clients, prices or contacts.

← Back to Blog · Contact bioaccess®